Skip to main content
SpringerLink
Log in

Advances in haematology and oncology 2011: hepatocellular carcinoma (HCC)

  • comment
  • Published:
memo - Magazine of European Medical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–2.

    Article  PubMed  Google Scholar 

  2. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer. EASL-EORTC. Clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908–43.

    Google Scholar 

  3. Sangiovanni A, Manini MA, Iavarone M, Romeo R, Forzenigo LV, Fraquelli M, et al. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut. 2010;59:638–44.

    Article  PubMed  Google Scholar 

  4. Lencioni R, Llovet JM, Han G, Tak W-Y, Yang J, Leberre M-A, et al. Sorafenib or placebo in combination with transarterial chemoembolization (TACE) with doxorubicin-eluting beads (DEBDOX) for intermediate-stage hepatocellular carcinoma (HCC): Phase II, randomized, double-blind SPACE trial. J Clin Oncol. 2012;30:LBA154.

    Google Scholar 

Download references

Conflict of interest

Dr. M. Peck-Radosavljevic is member of the Advisory Board and Investigator of Bayer Schering Pharma and Bristol-Meyers-Squibb, and has received Research Support and Speaker Honoraria from Bayer Schering Pharma.

Author information

Authors and Affiliations

  1. Department of Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Waehringer Gurtel 18–20, 1090, Wien, Austria

    Markus Peck-Radosavljevic MD

Authors
  1. Markus Peck-Radosavljevic MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Markus Peck-Radosavljevic MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Peck-Radosavljevic, M. Advances in haematology and oncology 2011: hepatocellular carcinoma (HCC). memo 5, 161–162 (2012). https://doi.org/10.1007/s12254-012-0009-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12254-012-0009-0

Keywords

Search

Navigation